Actinogen Medical Limited (ATGGF)

Actinogen Medical Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 11, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	97	48	111	48	62	162
Market Cap Growth	29.14%	-56.84%	129.54%	-21.84%	-61.78%	854.59%
Enterprise Value	93	33	103	39	47	152
Last Close Price	0.03	0.02	0.01	0.01	0.02	0.02
PS Ratio	19.78	13.31	16.75	14.86	24.67	108.80
PB Ratio	17.41	3.99	8.45	5.42	4.13	12.37
P/TBV Ratio	21.60	4.41	9.45	6.61	4.72	14.97
EV/Sales Ratio	17.60	9.20	15.60	11.93	18.61	102.47
Debt / Equity Ratio	0.03	0.18	0.02	0.01	0.01	0.01
Net Debt / Equity Ratio	-0.75	-0.72	-0.46	-0.62	-0.74	-0.76
Net Debt / EBITDA Ratio	0.35	0.88	0.71	0.79	1.76	3.67
Net Debt / FCF Ratio	0.38	1.74	0.54	0.96	1.70	7.64
Asset Turnover	0.41	0.24	0.54	0.25	0.18	0.13
Quick Ratio	4.17	3.74	13.83	6.99	13.73	19.87
Current Ratio	4.19	3.76	13.91	7.04	13.80	19.99
Return on Equity (ROE)	-110.77%	-77.47%	-78.81%	-61.18%	-48.46%	-27.62%
Return on Assets (ROA)	-63.83%	-41.91%	-45.37%	-35.65%	-28.59%	-16.16%
Return on Capital Employed (ROCE)	-216.20%	-82.90%	-66.40%	-81.90%	-43.70%	-22.20%
Earnings Yield	-12.29%	-20.16%	-7.84%	-14.80%	-10.58%	-1.81%
FCF Yield	-11.29%	-10.39%	-10.20%	-12.02%	-10.60%	-0.80%
Buyback Yield / Dilution	-19.05%	-37.04%	-20.69%	-4.92%	-22.20%	-25.69%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.